Market Place
Sourcing Support
Takeda eyes $3B from emerging-market asset cull
22 Jan 2019 //
FIERCE PHARMA
In the midst of an R&D shift, Takeda inks $790M cancer collab with Crescendo
11 Oct 2016 //
FIERCE BIOTECH
Indian patents controller grants patent to Amgen for its ANTI-GM-CSF MAB
29 Dec 2015 //
TWOFOURINSIGHT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.